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ABSTRACT
The major forms of testosterone-regulated RP2 messenger RNA (also known as
MAK mRNA and pMK908) in the mouse kidney were characterized by examining eDNA
and genomic clones. Three sizes of RP2 mRNA are detected by Northern blot analysis
and these were shown to result from polyadenylation at three distinct sites within the
primary transcript of this single-copy gene. The complete RP2 mRNA sequence was
obtained from overlapping cDNA clones, revealing an open reading frame of 357 amino
acids that corresponds to a protein of 40,365 daltons. The detection of RP2 mRNA in
all tissues examined to date suggests that the RP2 protein may function in a
housekeeping role in all cells. This is supported by the finding of a high percentage of
G + C residues at the 5' end of the gene, including a sequence homologous to the
binding site of the transcription factor Spl, which has been suggested to affect the
regulation of other housekeeping genes that have been characterized. An examination
of the amino acid sequence indicates that the RP2 protein is proline-rich and is
composed of alternating alpha-helix and beta-sheet regions. RP2 is probably not
integrated into a membrane structure in the cell as it does not appear to contain
hydrophobic regions capable of spanning a membrane.
INTRODUCTION
RP2 messenger RNA was first Identified as a testosterone-inducible gene
product by the differential screening of a mouse kidney cDNA library using cDNA
probes generated from uninduced and testosterone-induced kidney mRNA (1). The
mRNA was originally termed pMK908 RNA after the cDNA clone that was used in the
initial characterization. It was later given the more descriptive name MAK (mouse-
androgen-kidney, ref. 2), whereas RP2 was used to designate a polymorphism in the
gene (10). We use the term RP2 to avoid confusion in references to this gene and its
mRNAs.
RP2 mRNA comprises approximately 0.1 to 0.2% of the polyadenylated RNA in
mouse kidney. Stimulation by the hormone testosterone rapidly raises this level to
nearly 1%, making RP2 a major product of the kidney (1,2). RP2 is one of only a few
gene products known to be inducible in this tissue by testosterone. Others include s-
glucuronidase (3), alcohol dehydrogenase (4), arginase (5), ornithine decarboxylase (6),
KAP (7), and transferase 11 (8). Testosterone is also known to regulate RP2 mRNA
© I RL Press Limited, Oxford, England.
Nucleic Acids ResearchVolume 14 Number 13 1986
5159
Nucleic Acids Research
levels in the liver. Low amounts of RP2 mRNA have been detected in submaxillary
gland, brain, heart, muscle, and testes tissues. Hormones produced or controlled by
the pituitary gland have no effect on the regulation of RP2 mRNA levels in the kidney
(2).
Two major sets of RP2 mRNAs are differentially expressed in the tissues that
have been studied. Three RP2 species that are most abundant in kidney, liver, and
submaxillary gland are 1350, 1450, and 1950 nt in length (2,9). These same three
mRNAs are expressed at low levels in brain and muscle, but the more abundant RP2
mRNAs in these tissues are 1050, 1150, and 1650 nt long (2, D.K., unpublished
observations). All of these different mRNAs are produced by the transcription of a
single gene (2,10). Previous work has reported two different polyadenylation sites that
are recognized to produce the 1450 and 1950 nt mRNAs In the kidney (9). In this paper
we identify a third polyadenylation site, responsible for the generation of the 1350 nt
species.
The hormonal regulation and the tissue-specific production of different size
classes of mRNA from it make RP2 an interesting gene for study. We now present the
complete sequence of the kidney mRNAs and the RP2 amino acid sequence as deduced
from cDNA and genomic clones. This information allows preliminary conclusions to be
drawn concerning the functional role of RP2 protein within the cell and provides
essential groundwork for continued study of hormonal and tissue-specific mechanisms
controlling gene expression.
MATERIALS AND METHODS
Clones.
cDNA clones were Isolated from a library prepared from poly(A) cytoplasmic
RNA from kidneys of DBA/LiHa mice induced with subcutaneous testosterone pellets
(11). Screening of the cDNA library was described previously (2). Genomic clones
were isolated from a cosmid library that was constructed from B10.D2-H-2dml mouse
liver DNA (12) by following the procedure of Steinmetz et al (13). The probe used in
the genomic screening was the purified 1060 bp Bgl I fragment from the middle of
cDNA clone pMAK-1 (see Figure 1). Sequencing of the clones was accomplished by the
method of Maxam and Gilbert (14).
RNA Analysis.
Total cytoplasmic RNA was isolated from mouse kidneys as previously described
(2). The probe for the S1 nuclease analysis of the 1350 and 1450 nt mRNA
polyadenylation sites was the 412 bp Hinf I fragment that Is shown in Figure 2. This
fragment was 3' end-labeled with the Klenow fragment of DNA polymerase I and
strand-separated (15). S1 nuclease analysis was performed by the method of Berk and
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Sharp (16) as modified by Weaver and Weissmann (17). Total kidney RNA (10 pg) was
hybridized to excess probe at 500C for 3.75 hrs. Nonhybridizing DNA probe was
subsequently digested with 400 U of S1 nuclease (Sigma Chemical Co.) per ml at 180C
for 1 hour. The resulting protected end-labeled DNA fragments were electrophoresed
on a 5% polyacrylamide -50% urea denaturing gel and autoradiographed.
The 5' end of kidney RP2 transcripts was identified by primer extension analysis.
The 16-base long oligonucleotide 5'-CAGCTGCTCGAGCTGC-3', which was 5' end-
labeled with [y-32P] ATP by polynucleotide kinase, was hybridized to 40 ug of kidney
cytoplasmic RNA from C57B1/6J mice at 50°C for 2 hrs. The RNA-DNA hybrids were
ethanol precipitated, and the pellets were rinsed with cold 70% ethanol. Reverse
transcription was performed with Moloney murine leukemia virus reverse transcriptase
following the protocol recommended by the manufacturer (Bethesda Research
Laboratories). Products of the reaction were electrophoresed on an 8%
polyacrylamide-50% urea gel and autoradiographed.
A preparative-scale primer extension reaction was performed with 500 ig of
testosterone-induced C57B1/6J mouse total cytoplasmic kidney RNA. Hybridization
occurred at 500C over 40 hrs. Reverse transcription was performed with 200 units of
the reverse transcriptase in a 100 jil volume at 370C for 1 hr. The resulting product
was eluted from an 8% polyacrylamide-50% urea gel after it was identified by
autoradiography. The DNA was then passed through silanized glass wool, phenol and
chloroform extracted, ethanol precipitated, resuspended in distilled water, and
subjected to Maxam and Gilbert sequencing reactions (14). The sequence of the first
61 nucleotides of the RP2 mRNA was determined in this manner.
Data Analysis.
The GenBank DNA sequence databank was searched for homologies to the RP2
cDNA sequence by Greg Wernke of the University of Cincinnati, using the Beckman
Laboratories DNA analysis program. The RP2 amino acid sequence obtained from the
cDNA was compared by Russell Doolittle to the contents of a protein databank
maintained by himself at the University of California, San Diego. All other sequence
analysis was performed with the International Biotechnologies, Inc. Pustell sequence
analysis program.
RESULTS
Overlapping RP2 eDNA clones (Figure 1) were obtained from screenings of a
DBA/LiHa testosterone-induced mouse kidney cDNA library (2,9). It is known that the
sizes of RP2 mRNA In DBA/LiHa mouse kidney are 1350, 1450, and 2150 nt, while the
sizes of RP2 mRNA in C57B1/6J mice are 1350, 1450, and 1950 nt. The difference in
the sizes of the largest mRNA between these strains is due to the presence of a
polymorphic Bi repetitive element in the 3' untranslated region in DBA mice (9). In
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Figure 1
Restriction maps of overlapping RP2 cDNA clones from the DBA/LIHa library.
Xho I, X; Sma I, S; Pvu II, P; Rsa I, R; Bgl l, B. The locations of an oligonucleotide
used in primer-extension analysils and the 1060 bp Bgl I fragment used in the screen of
the genomic library are also Indicated. The sequencing strategy employed for each
clone is shown below the maps. Closed circles Indicate fragments sequenced from
their 5' ends and open cirles indicate those sequenced from their 3' ends. The dashed
line represents flanking vector DNA that was also sequenced.
other respects the RP2 mRNAs from the two strains are the same. Taken together,
these overlapping cDNA clones represent essentially the full length of the mRNAs in
DBA mice. Their Identical restriction maps reflect what was revealed at the
nucleotide level; that these five cDNA clones represent mRNAs transcribed from the
same gene.
The basis for the production of the 1450 and the 1950/2150 nt mRNAs from the
single-copy RP2 gene was explained previously by the alternate use of two
polyadenylation sites (9). This was determined by Si nuclease mappilng. Additional Si
nuclease mapping has now established that a third polyadenylation site is utilized to
produce the 1350 nt mRNA. An 51 nuclease protection assay was performed with the
412 base long 3' end-labeled Hinf I fragment diagrammed in Figure 2. This fragment
spans a region which includes the previously reported 1450 polyadenylation site. The
band at 170 bases represents probe that was protected over this length by the 1350 nt
mRNA. A band approximately 100 bases larger at position 265 corresponds to probe
that was protected by the 1450 nt mRNA. Thus the two polyadenylation sites are
separated from each other by an amount equivalent to the size differences observed on
Northern blots. The same signals were generated from both DBA/2J and C57B1/6J
kidney RNA, and stronger signals were seen when the RNA was prepared from
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Figure 2
Si nuclease analysis of multiple RP2 polyadenylation sites.
Part A. The 412 base 3' end-labeled Hinf I fragment probe spans two polyadenylation
sites indicated on the map (arrows). This single-stranded probe was hybridized to
equivalent amounts of testosterone-induced or uninduced total cytoplasmic kidney
RNA from DBA/2J and C57B1/6J mice and subjected to Si nuclease digestion. The
resulting bands represent protection by the 1350 and 1450 nt RP2 mRNAs. The length
of the poly (A) tails is assumed to be approximately 140 bases. Differences in signal
intensities were also observed between testosterone-induced and uninduced female
mice. This induction was previously determined to be 8-fold (2). Lanes: 1, probe
alone; 2, yeast tRNA (negative control); 3, DBA/2J induced females; 4, DBA/2J
uninduced females; 5, C57B1/6J Induced females; 6, C57B1/6J uninduced females; 7
and 8, DNA size markers.
Part B. The three RP2 polyadenylation signals are compared to the consensus signal
(18).
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1 10
Met Sar Ser Ser Ser Ser Trp Arg Arg Ala Ala Thr Val Met Leu Ala
AC GTC CCG CCA CTC CTA AGG GGG ATC CGA AGG ACG CCG GCC ATG AGC AGC TCG AGC AGC TGG CGG CGG GCA GCC ACC GTG ATG TTG GCC 89
20 30 40
Ala Gly Trp Thr His Ser Ser Pro Ala Gly Phe Arg Leu Lau Lau Lou Gin Arg Ala Gln Asn Gin Arg Phe Leu Pro Gly Ala His Val
GCA GGC TGG ACC CAC TCG AGC CCG GCC GGC TTC CGG CTG CTG CTT CTC CAG CGA GCA CAA AAC CAG CGC TTC TTG CCC GGC GCG CAC GTC 179
50 60 70
Phe Pro Gly Gly Val Lau Asp Ala Ala Asp Ser Ser Pro Asp Trp Val Arg Lau Phe Ala Pro Arg His Thr Pro Pro Arg Phe Gly Leu
TTC CCG GGC GGC GTG CTG GAC GCG GCC GAC AGC TCA CCC GAC TGG GTG CGT CTG TTC GCG CCT CGG CAC ACG CCG CCG CGC TTC GGC CTA 269
80 90 100
Gly Pro Glu Pro Pro Arg Gin Pro Pro Phe Pro Gly Lou Ser His Gly Asp Ala Asp Pro Ala Ala Leu Pro Asp Asp Val Ala Leu Arg
GGC CCG GAG CCC CCT CGG CAA CCC CCC TTC CCC GGG CTG TCC CAC GGC GAC GCG GAC CCC GCG GCG CTG CCC GAT GAC GTA GCG CTG CGC 359
110 120 130
lie Cys Ala Ile Arg Glu Ala Phe Glu Glu Ala Gly Vat Lau Lau Leu Ang Pro Arg Asp Ala Ala Pro Ala Ser Gln Glu Pro Ser Gin
ATC TGT GCC ATC CGC GAA GCC TTC GAG GAG GCG GGG GTG CTG CTC CTG CGG CCG CGG GAC GCG GCT CCA GCT TCT CAG GAG CCC AGT CAG 449
140 150 160
Ala Leu Oar Pro Pro Ala Gly Leu Ala Glu Trp Arg Ser Arg Val ArgSp r Asp Pro Arg Cys Phe Leu Gln Lou Cys Ala His Leu Asp
GCG CTG TCG CCT CCG GCC GGC CTG GCC GAA TGG CGC TCG CGC GTG CGC AGT GAC CCG CGC TGC TTC CTC CAG CTG TGT GCG CAC CTA GAC 539
170 180 190
Cys Thr Pro Asp Ilt Trp Ala Leu His Asp Trp Gly Gly Trp Lou Thr Pro Tyr Gly Arg Thr lie Arg Arg Phe Asp Thr Thr Phe Pha
TGC ACG CCT GAC ATC TGG GCG CTG CAC GAC TGG GGC GGA TGG CTC ACC CCG TAT GGG CGA ACC ATC CGC CGT TTC GAC ACC ACC TTC TTC 629
200 210 220
Lou Cys Cys Lau Arg Asp Thr Pro Arg Val Glu Pro Asp Val Ala Glu Val Val Gly Tyr Gin Trp Leu Ser Pro Ser Glu Ala Thr Gl
CTG TGC TGC CTG CGC GAC ACT CCG CGC GTG GAG CCC GAC GTG GCC GAG GTG GTG GGC TAC CAG TGG TTG TCC CCA TCA GAG GCA ACT GAA 719
230 240 250
Cys Phe Lou Ser Lys Glu lie Trp Lou Ala Pro Pro Gin Phe Tyr Glu Met Atg Arg Lau Glu Asn Phe Ala Ser Lou Ser Ala Leu Tyr
TGT TTC CTA TCA AAA GAA ATC TGG CTG GCA CCA CCA CAG TTC TAT GAA ATG AGA AGA CTT GAA AAC UT GCC TCT CTC TCT GCT CTG TAT 800
260 270 280
Arg Phe Cys Ser Asp Arg Pro Ser Dlu Val Pro Glu Lys Trp Lou Pro lie lie Leu Lou Thr Ser Asp Gly Thr Ile His Leu Lau Pro
AGA TTr TGT TCG DAT CGC CCA TCA GAA GTA CCI GAG MA TGG CTG CCA ATA ATA CU TIA ACT TCT GAT GGC ACC ATC CAT CU CTC CCA 899
290 300 310
Gly Asp Glu Leu Tyr Val Lys Asp Ser Asp Phe Lou Glu Lys Asn Mat Ser Thr Asp Lys Lys Thr Glu Glu lt Val Lys Glu Gly Lys
GGA GAT GAG CTG TAT GTG AAA GAC TCA GAC TTC TTG GM AAG AAT ATG TCT ACT GAC AAA AAG ACT GAA GAA ATC GTG AAG GAA GGC A 989
320 330 340
Val Leu Asn Arg Val Val Ite His SeO Pro Tyr Val Tyr Glu lie Tyr Met Thr Leu Pro Ser Glu Asn Lys His Val Tyr Pro Arg Asn
GTC CTT AAC CGA GTT GTG ATC CAC AGT CCC TAT GTG TAC GAA ATC TAC ATG ACT CTT CCG TCA GAG AAT AAG CAC GTG TAC CCT AGG AAC 1079
350
Tyr lie Val Asn Lys Arg Tyr Thr Ala His Lou END
TAC ATA GTG AAT AAG AGA TAT ACT GCC CAC CTG TAA GCC GCA CTA CTT ATG TAC TGT TAG CAA ATA ATG AAG ATT GAC TGA ACC TGT CTA 1169
AAA ATC TAA GGA ATG TAC CCA TAA AAG TCA CAA TGA GGT GTt ACC TGT GTC ATG TGT GTT TTG GGA GCC TCT GCC ATT TGT CAG ACT GCA 1259
CAG CAA GCC AAA TGT AGA ATG GAC GAA GTA GTA AAG CTC TTG TCA CCA AGA TGA ACG GTT TCA CGA CAG TTG TTT TAT TAG TTG AAC ATT 1349
GGA AAG TGG TCT CCT GCC ATC CTC TAA CTG TCC CAC GCG TTA GCG GTT TCC TGG TGC GCT GTG GAG ACT GAG CCC TGG CTC TCT TAC ACT 1439
TTC GCA GGA ATT GAT TCC GAG ATA CCT AGT TAA AGA GTG CTG AGG GTC AGA TGT GAG AGG ACT CCC ACT TGC TCC CTG GTT GGT AGC CAT 1529
UT GGC AGG TTG TGA AA CTG AGG GGC AGG CTT TAG CTA GGG TCT TGA GGG ATC GAG TCT TTT TGT TGT TGT TTG UTT TG TTT TI GAG 1619
ACA GGG TTT CTC TGT AGC CCT GGC TGT CCT GGA ACT CAC TCT GTA GAC CAG GCT GGC CTC GM CTC AGA AAT CCA CCT ACC TCT DCC TCC 1709
CAA GTG CTG AAA TTA AAG GTG CGC GCC ACC ACT ACC CGG CCG AGG GAT CGA GTC TTA ACT CTG TGC CAG CAG GGT CCT TTG TTT CTC CAT 1799
CTG AGG AGA TGC GAG CAG ACT TTG CCT CAG DTT TCT GCC TCC AGG AAG GTC CCT TGT TTC UTG TGT CGG GCT TTT GAT CAC AGT AAG GAA 1889
AGT TAA TAT AAA TAA ACA GTG ATC ATC CTT CM ADG GGA TGT CAT GGT CGT GCC GTA GAA TCA ACT TGA TAA TTA ACA TAC AGT ATT TGC 1979
ATT AAA ACC AAA TGA CAT TCA TTT tG (poly A) 2005
Figure 3
Complete sequence of DBA/LiHa mouse kidney RP2 mRNA and the amino acid
sequence deduced from it. Regions calculated to likely form alpha-helix and beta-
sheet secondary structures in the protein are indicated by shaded and open bars,
respectively, below the sequence; three regions capable of forming either
conformation are Indicated by discontinuous bars. The three polyadenylation sites are
indicated by vertical arrows. The Bi repetitive element is underlined and the 14 bp
direct flanking repeats created by the insertion of the Bi element are overlined with
arrows. C57B1/6J mice, representing the other form of the polymorphism, are
precisely missing the Bi repeat, its 3' flanking region, and one of the 14 bp direct
repeats. This has been sized as a 200 nt difference between strains in the largest RP2
mRNA. The 3' untranslated region from base 1184 has been published previously (9).
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Figure 4
Hydropathy plot of RP2 protein sequence. Hydrophobic (plotted above the axis)
and hydrophilic (below the axis) regions of the protein were plotted by computer over
the length of the amino acid sequence. Each point represents the average polarity of
nine amino acids spanning each position.
tetosterone-induced mice. A faint signal detected at position 285 in some lanes is not
due to polyadenylation directed by any sequence known to function as a
polyadenylation signal, nor does the sequence resemble an intron splice donor site.
Sequences surrounding the three RP2 polyadenylation sites are aligned with the
polyadenylation consensus signal derived by Gil and Proudfoot (18) in part B of Figure
2. It is noted that none of the three sequences contains the very highly conserved
portion of the consensus sequence, AATAAA (19). The three different variations of
this sequence that are recognized as polyadenylation signals in the RP2 transcript have
been reported to occur infrequently near the polyadenylation sites of other mRNAs,
however (20,21).
The entire sequence of the largest RP2 mRNA from DBA mice is presented and
translated in Figure 3. All three of the RP2 mRNAs detected in the kidney share the
same amino acid coding region, differing only in the position of the polyadenylation
site which is used. These are shown by vertical arrows at positions 1211, 1306, and
2005. The B1 repetitive element which creates the polymorphic size differences
between mouse strains in the largest mRNA is underlined and Is followed by the
characteristic A-rich tract, represented here by T's because the element was inserted
in the opposite transcriptional orientation with respect to RP2. The element is
flanked by 14 bp directly repeated sequences (overlined arrows). A relatively short 5'
untranslated region precedes two potential methionine initiation codons. Initiation at
the first of these (as shown) is likely to be favored because the surrounding sequence
more closely resembles the translation Initiation consensus sequence described by
Kozak (22). Initiation at the in-frame methionine codon at nucleic acid position 81 is
the alternative possibility. This question can only be unequivocably resolved by the
purification and amino acid sequence analysis of the RP2 protein. An open reading
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frame of 357 codons follows the initial methionine, resulting in a polypeptide of 40,365
daltons. This agrees with the previous sizings of the in vitro synthesized polypeptide
as 42,000 daltons (2) and 43,000 daltons (1). The amino acid sequence is rich in proline
residues (9.8%) which undoubtably have a significant effect on the secondary structure
of the protein by introducing bends and distorting helical regions. Sequences that have
a high probablility of forming alpha-helix and beta-sheet structures (23) are indicated
by shaded bars and open bars, respectively, in Figure 3. The regions which could form
either structure are indicated by discontinuous bars. Those structures with a minimum
length of 7 amino acids are shown. The N-terminus of the amino acid sequence was
searched for similarities to signal sequences that direct the insertion of nascent
polypeptides into membranes (24), but none could be identified. This suggests that the
RP2 protein is not sequestered by the endoplasmic reticulum.
The amino acid sequence was also examined by hydropathy analysis (Figure 4).
The polarity of the RP2 amino acid sequence was averaged over nine residues at a
time and plotted over the full length of the sequence according to the algorithm of
Kyte and Doolittle (25). None of the hydrophobic regions (indicated above the axis)
are long enough or hydrophobic enough (a minimum of 19 residues with an average
hydropathy greater than 1.6) to be capable of spanning a membrane. The lack of a
transmembrane region and the lack of a signal sequence both indicate that the RP2
protein is probably not directly associated with membrane structures within the cell.
In order to determine whether the cDNA clones truly represent the entire length
of RP2 mRNA, primer extension analysis was performed. This enabled us to determine
the number and sequence of any missing bases at the 5' end. A 16 base long
oligonucleotide was synthesized based on sequence at the 5' end of pMAK-4, the cDNA
clone which extends farthest in that direction. The oligonucleotide was
complementary to the coding strand starting at base 61 In Figure 3 and its position
relative to the rest of the cDNA Is Indicated in Figure 1. The oligonucleotide was
labeled with 32P at Its 5' end by T4 polynucleotide kinase and was hybridized to RNA
from both testosterone-induced and uninduced C57B1/6J mouse kidneys. Reverse
transcriptase was then used to extend the oligonucleotide primer to the mRNA cap
site. When the reaction products were electrophoresed on a denaturing gel and
autoradiographed, the distance from the end-labeled base of the oligonucleotide to the
cap site could be measured. This data is shown in Figure 5. A strong band at 61 bases
is generated from testosterone-induced kidney RNA whereas a much weaker band is
seen at the same position when an equivalent amount of RNA from uninduced mouse
kidney is used. Identical results were obtained using kidney RNA from DBA/2J mice
(data not shown). Very faint bands in both lanes at approximately 200 bases do not
reflect the induction and were not present in all repetitions of this experiment.
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Figure 5
Analysis of the 5' end of RP2 mRNA by primer extension of an oligonucleotide.
A 16 base long oligonucleotide complementary to the 5' end of the mRNA was
synthesized based on sequence from the eDNA clone pMAK-4 (see figure 1). The
oligonucleotide was labeled with 32P at its own 5' end and hybridized to equivalent
amounts of testosterone-induced and uninduced kildney RNA. The hybr'ids were then
extended to the mRNA cap site by reverse transcriptase and the resulting product
sized on a polyacrylamide gel. An autoradiograph is shown. The band at 61 bases
indicates the site of initiation of transcription of all three major kidney RP2 mRNAs.
The primer extension result Indicated that 28 bases at the 5' end of the mRNA
were missing from our cDNA clones. A preparative-scale primer extension reaction
was performed on testosterone-induced kidney RNA and the resulting product was
subjected to Maxam and Gilbert sequencing. This allowed the determination of the
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Figure 6
Map of the 5' half of the RP2 gene and sequence of the promoter region. The 5'
end of the RP2 gene was isolated from a cosmid library and mapped with the
restriction enzymes noted. The sequence of the region surrounding the transcription
initiation site Is presented below the map. The TATA box is overlined and a potential
Spl binding site is overlined with dashes. A vertical arrow denotes the transcriptin
initiation, or cap site. Hind III, H; Eco Rl, E; Xho I, X; Sma I, S; Bam Hi, B.
missing sequence directly from the mRNA. The sequence of this region was later
confirmed after an RP2 genomic clone was isolated and the promoter region
identified.
The nucleotide sequence of the RP2 gene promoter region was obtained from a
cosmid clone isolated from a mouse genomic library. Sequence analysis was performed
from the 5'-most Xho I site shown in Figure 6, providing information on the region
immediately surrounding the mRNA cap site. The sequence from -60 bases upstream
of the cap site to the initiator methionine codon at +42 is presented below the map. A
TATA box is overlined in the expected position at -24. A sequence upstream of that
(overlined dashes) resembles the Spl transcription factor binding site, CCGCCC (26).
It Is interesting to note an abrupt change in the G + C content of the DNA that occurs
at the cap site (arrow). Upstream of the cap site the sequence is 50% rich in G and C
residues, whereas downstream this ratio is 68%.
DISCUSSION
Three major size classes of RP2 mRNA are transcribed in the mouse kidney from
a single gene. We have demonstrated that all of these mRNAs share the same 5'
terminus and differ only In their sites of polyadenylation. The three mRNAs encode
the same polypeptide sequence, which has been determined to be 357 amino acids long.
The predicted size of this polypeptide is 40,365 daltons, in good agreement with the
previously sized In vitro translation product (1,2). Additional information which can be
gleaned from the amino acid sequence includes the fact that the RP2 protein does not
contain a classic signal sequence that might direct transport of the protein across a
membrane (24,27). The hydropathy plot of the amino acid sequence indicates, in
addition, that there are no regions within the primary structure of the protein that are
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capable of spanning a membrane. Therefore, this testosterone-inducible gene product
most likely exists in soluble form within cells of the kidney.
Searches were made of the available DNA and protein sequence databanks to
determine whether an alignment could be made which would identify or further
characterize the funciton of RP2. The results indicate that the sequence presented
here is the first to be reported for this gene and its product. No significant
homologies were found between the coding region of the RP2 mRNA and the contents
of the GenBank DNA sequence databank. Similarly, the search of an amino acid
sequence databank maintained by Russell Doolittle at the University of California, San
Diego, revealed no alignment with any previously sequenced protein. The best match
to RP2 that was observed showed some similarity (15 out of 55 amino acids) to the gag
protein of a feline sarcoma virus (28). The determination of the amino acid sequence
facilitates continued investigation of the role of RP2 within the kidney; moreover,
polypeptides synthesized based on this information can now be used to generate
antibodies, enabling the purification and further characterization of large quantities of
the protein.
Several pieces of information suggest that RP2 protein may be functional in
some form in all cells. RP2 mRNA has been detected in all the tissues that have been
examined for its presence (kidney, liver, submaxillary gland, heart, brain, muscle, and
testes, ref. 2), although the sizes of the mRNAs vary. This variation suggests that
there are likely to be tissue-specific RNA processing mechanisms involved in addition
to the polyadenylation sites that are utilized in the kidney. The isolation of RP2
genomic sequences will help to address this question in the future. For the present, it
is known that the promoter region of this gene shares two characteristics with other
genes that function in a ubiquitous, or housekeeping role. A region which resembles
the binding site of the transcription factor Spl has been identified in the 5' flanking
region, and 5' region of the mRNA is notably (68%) rich in G + C residues. Sequenced
housekeeping genes with these features include mouse APRT (29), mouse HPRT (30),
human DHFR (31), human triosephosphate isomerase (32), and hamster HMG CoA
reductase (33).
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